fi
rst
sar
case
report
around
world
januari
hospit
heyuan
citi
guangdong
provinc
hospit
two
patient
sever
pulmonari
infect
unknown
caus
fi
rst
traceabl
report
sar
around
global
februari
sar
fi
rst
diagnos
expert
carlor
urbani
hanoi
vietnam
also
name
new
unexplain
diseas
ever
cute
r
espiratori
yndrome
sar
follow
emerg
sar
govern
around
world
attach
great
import
took
consecut
effect
control
prevent
measur
rein
infect
rapidli
control
short
time
april
elimin
vietnam
name
list
sarsinfect
area
made
vietnam
fi
rst
get
rid
sar
outbreak
sinc
numer
countri
also
tick
list
juli
announc
remov
taiwan
china
sarsaffect
area
list
also
last
present
sarsaffect
area
around
world
signal
victori
global
battl
sar
end
septemb
total
peopl
infect
deceas
mortal
april
new
coronaviru
never
seen
announc
caus
sar
joint
effort
global
scientist
biolog
scientifi
c
technolog
advanc
enabl
establish
intern
sar
research
network
separ
identifi
cation
sar
coronaviru
confi
rmation
sar
pathogenesi
canadian
laboratori
exclud
infl
uenza
viru
b
parainfl
uenza
viru
type
adenoviru
respiratori
syncyti
viru
scan
electron
microscopi
direct
fl
uoresc
antibodi
test
also
conduct
immunohistochemistri
corps
tissu
dead
patient
virus
includ
infl
uenza
viru
b
respiratori
syncyti
viru
adenoviru
circoviru
hantaan
viru
measl
viru
intestin
tract
viru
pneumonia
mycoplasma
chlamydia
show
neg
scholar
german
franc
america
hong
kong
taiwan
appli
specifi
c
pcr
test
target
correspond
pathogen
examin
pneumonia
mycoplasma
pneumonia
chlamydia
human
cytomegaloviru
circoviru
herp
viru
human
coronaviru
arenavirus
bunyaviru
hantaan
viru
crimeancongo
hemorrhag
fever
viru
also
indic
neg
march
hong
kong
univers
fi
rstli
separ
cultur
coronaviru
nasopharyng
specimen
sar
patient
vero
cell
sever
laboratori
canada
america
diseas
center
sar
intern
coordin
group
also
cultur
coronaviru
april
base
aforement
research
fi
nding
declar
new
coronaviru
pathogen
sar
name
sar
coronaviru
sarscov
sarscov
singlestrand
posit
rna
viru
belong
genu
coronaviru
coronavirida
famili
nidoviral
order
bear
great
morpholog
resembl
known
human
coronavirus
electr
microscop
sar
coronaviru
present
pleomorph
spheric
particl
envelop
vero
cell
vitro
diamet
mm
distinct
coronaviru
morpholog
characterist
rodlik
surfac
project
nm
long
protrud
outsid
viral
envelop
form
corona
separ
cultur
virus
vero
cell
viral
particl
mostli
found
vacuol
insid
cell
electr
microscop
mainli
hollow
particl
virus
outsid
cell
observ
spike
coronaviru
mainli
compos
nucleic
acid
protein
carbon
lipid
sarscov
rel
stabl
human
specimen
environ
rel
sensit
chemic
physic
factor
virus
could
kill
exposur
ultraviolet
ray
min
envelop
sarscov
contain
lipoid
sensit
lipid
solvent
could
inactiv
ether
chloroform
tween
ethyl
alcohol
methanol
pancreat
enzym
ultraviolet
ray
ether
could
steril
viru
complet
h
ethyl
alcohol
could
deactiv
viru
min
disinfect
contain
chlorin
may
kill
viru
aft
sar
fi
rst
newli
emerg
infecti
diseas
twentyfi
rst
centuri
sinc
fi
rst
case
detect
guangdong
januari
sar
spread
countri
fi
state
unpreced
speed
sever
month
accord
report
sar
epidem
found
total
main
sourc
infect
sar
patient
infecti
sourc
anim
need
consolid
regard
symptomat
patient
effect
spread
sarscov
present
still
lack
clinic
proof
asymptomat
sar
patient
could
spread
sar
coronaviru
case
highli
contagi
abl
directli
infect
patient
call
superspread
fi
superspread
singapor
found
infect
peopl
power
infecti
attribut
high
viral
load
insid
patient
could
discharg
abund
virus
via
respiratori
tract
short
time
specialist
depart
microbiolog
hong
kong
univers
guangdong
provinci
diseas
control
prevent
center
test
abund
sar
coronavirus
sampl
collect
civet
cat
sold
guangzhou
shenzhen
suggest
human
sar
coronaviru
might
origin
civet
cat
sar
viru
spread
mainli
respiratori
tract
also
spread
aerosol
droplet
high
level
sar
coronaviru
could
detect
throat
swab
sputum
specimen
patient
acut
phase
virus
discharg
patient
via
cough
would
exist
air
within
certain
radiu
thu
form
shortdist
respiratori
tract
droplet
spread
main
rout
sar
dissemin
indirect
direct
contact
spread
could
also
spread
sar
coronaviru
could
spread
contact
respiratori
tract
secret
mouth
nose
via
contamin
hand
toy
virus
prolifer
abundantli
respiratori
tract
exfoli
cell
contain
infecti
virus
could
expel
outsid
bodi
patient
respir
cough
sneez
suspend
air
thu
form
aerosol
sar
viru
cough
sneez
could
greatli
contribut
product
sar
viru
aerosol
sar
new
type
infecti
diseas
peopl
effect
expos
sar
pathogen
vulner
present
data
reveal
sar
acut
selflimit
infecti
diseas
neutral
antibodi
sar
could
detect
week
onset
howev
chang
pattern
neutral
antibodi
titer
fulli
elucid
epidem
sar
mainli
take
place
winter
spring
sar
outbreak
mainli
concentr
coastal
tourism
citi
prosper
economi
dens
popul
conveni
transport
particularli
air
transport
perspect
intern
geographi
sar
primarili
occur
southeastern
countri
region
includ
china
mainland
hong
kong
taiwan
singapor
vietnam
analysi
statist
variou
countri
show
sar
onset
mainli
record
young
popul
age
year
old
occupi
around
total
sar
coronaviru
sarscov
mutant
coronavirida
pathogen
host
follow
two
aspect
fi
rstli
viral
infect
could
directli
damag
structur
function
infect
cell
trigger
cell
apoptosi
secondli
immun
reaction
releas
variou
cytokin
induc
viral
infect
could
elimin
infecti
pathogen
also
may
deal
sever
damag
histiocyt
due
excess
immun
reaction
member
coronavirida
singlechain
posit
rna
viru
taxonom
belong
nidoviral
arterivirida
homolog
analysi
sarscov
structur
protein
aminoacid
sequenc
show
main
structur
protein
spike
protein
membran
protein
n
nucleocapsid
protein
e
envelop
protein
bear
low
homolog
known
coronavirus
besid
bioinform
analysi
infer
sarscov
may
also
encod
nonstructur
protein
unknown
function
sarscov
specifi
c
protein
may
play
key
role
determin
viral
virul
sprotein
exist
viral
surfac
form
trimer
main
compon
construct
coron
structur
major
structur
protein
integr
viru
host
cell
receptor
fusion
viral
envelop
cell
membran
enabl
invas
virus
infect
sensit
cell
sarscov
could
replic
enorm
releas
virion
may
disturb
cell
metabol
directli
result
injuri
bodi
tissu
cell
earli
phase
diseas
continu
progress
phase
activ
immun
cell
lymphocyt
nk
cell
dc
cell
decreas
promin
extent
posit
correl
sever
condit
speed
progress
besid
dead
patient
detect
irrevers
signifi
cant
declin
howev
along
remiss
condit
entri
recoveri
phase
number
aforement
immun
cell
could
recov
extent
whose
chang
present
distinct
parallel
correl
diseas
evolut
dynam
observ
suggest
serum
preinfl
ammatori
cytokin
level
sar
patient
could
reach
peak
second
week
diseas
cours
rel
correspond
acut
aggrav
phase
consolid
immun
damag
sarscov
infect
autopsi
patient
die
infect
sar
reveal
sar
diseas
detriment
organ
whole
bodi
particularli
lung
tissu
immun
system
primari
patholog
chang
classifi
ed
sever
lung
lesion
immun
organ
impair
toxic
chang
organ
secondari
infect
caus
death
follow
diffus
lung
alveolar
damag
lead
progress
respiratori
failur
impair
liver
kidney
heart
sever
organ
may
induc
multipl
organ
failur
exacerb
condit
due
injuri
immun
organ
particularli
lymph
node
spleen
lymphocyt
decreas
immun
compromis
therefor
result
secondari
mycot
infect
lung
tissu
becom
swollen
heavier
accord
domest
report
left
lung
may
reach
g
averag
g
right
lung
g
averag
g
total
lung
g
averag
g
lung
tissu
appear
dark
red
textur
hard
indic
consolid
surfac
rel
smooth
free
pleural
adhes
lung
tissu
observ
blood
vessel
dilat
congest
spot
patchi
necrosi
hemorrhag
infarct
foci
focal
compensatori
emphysema
section
variou
lung
lobe
visual
outfl
ow
light
red
orand
foami
bloodstain
fl
uid
trachea
bronchi
found
exud
slight
mucoid
bloodstain
secret
pulmonari
hilar
lymph
node
reveal
slight
enlarg
pleural
caviti
without
effus
microscopi
reveal
bilater
diffus
sever
injuri
alveoli
character
acut
exud
hemorrhag
fi
brinou
infl
ammat
howev
injuri
may
inhomogen
divers
differ
lung
lobe
differ
part
lobe
characterist
chang
earli
phase
pulmonari
edema
homogen
pink
serou
fi
brinou
effus
fi
lling
alveolar
caviti
well
erythrocyt
leakag
caviti
effus
alveolar
caviti
may
condens
form
thinlay
membranelik
substanc
adher
alveolar
wall
name
format
hyalin
membran
fig
alveolar
epithelia
present
diffus
injuri
degener
necrosi
exfoli
orand
apoptot
type
ii
alveolar
epitheli
cell
observ
alveolar
caviti
similar
chang
desquam
pneumonia
fig
among
appear
like
apoptot
bodi
partial
region
type
ii
alveolar
epitheli
cell
macrophag
prolifer
activ
obviou
increas
cell
volum
distinct
nucleolu
case
cell
detect
fuse
form
syncyti
monocyt
multinucl
giant
cell
fig
alveolar
epithelia
case
examin
structur
similar
viral
inclus
bodi
mostli
spheric
eosinophil
stain
around
transpar
halo
visibl
fig
pulmonari
interstitium
alveolar
space
detect
high
dilat
congest
capillari
swell
exfoli
epitheli
cell
well
widen
latter
present
slight
lymphocyt
monocyt
infi
ltration
small
vessel
prolifer
enlarg
characterist
vascul
chang
region
observ
pulmonari
vascular
embol
fi
brinou
microthrombi
alveolar
capillari
alveolar
capillari
caviti
manifest
dilat
free
blood
compon
addit
patient
detect
lung
tissu
focal
hemorrhag
compensatori
emphysema
small
airway
necrot
infl
ammat
alveolar
collaps
shrinkag
patient
diseas
cours
three
week
manifest
fi
broblast
prolifer
alveolar
septa
individu
case
demonstr
organ
fi
brinou
exud
alveoli
fi
broblast
prolifer
give
rise
glomeruloid
structur
name
glomeruloid
organ
pneumonia
fig
bronchial
epitheli
cell
reveal
exfoli
scarc
exfoli
cilia
well
structur
similar
viral
inclus
squamou
cell
metaplasia
insid
bronchioli
detect
submucos
edema
infl
ammatori
cell
infi
ltration
serou
grandular
hyperplasia
hyperact
secret
pulmonari
hilar
lymph
node
demonstr
light
swell
present
differ
degre
congest
hemorrhag
necrosi
decreas
innat
lymphocyt
microscop
blood
sinu
lymph
node
present
grave
congest
dilat
lymphoid
nodul
atrophi
disappear
promin
cortex
lymphat
tissu
focal
necrosi
accompani
apoptosi
lymphocyt
fig
spleen
mostli
shrink
soft
textur
patchi
focal
hemorrhag
surfac
section
splenic
white
pulp
detect
obvious
atroph
absent
central
arteri
wall
thicken
endotheli
cell
swollen
partial
shed
peripher
lymphat
sheath
lymphocyt
deplet
greatli
germin
center
disappear
splenic
corpuscl
observ
plasma
protein
sediment
central
arteri
wall
white
pulp
margin
sinu
lymph
tissu
larg
patchi
necrosi
partial
remain
lymphocyt
apoptosi
splenic
sinu
insid
red
pulp
reveal
obviou
congest
focal
hemorrhag
necrosi
well
prolifer
histiocyt
fig
number
hematopoiet
cell
bone
marrow
declin
granulocyt
system
megakaryocyt
system
rel
inhibit
polychromat
erythroblast
present
small
focal
prolifer
tissu
brain
liver
kidney
heart
demonstr
vari
degre
congest
edema
degener
necrosi
well
infi
ltration
lymphocyt
secondari
bacteri
pneumonia
fungal
infect
may
occur
fig
initi
symptom
sar
frequent
fever
accompani
headach
gener
muscular
joint
sour
sore
often
without
nasal
discharg
sore
throat
upper
respiratori
tract
catarrh
symptom
pulmonari
sign
obviou
sign
distinct
systemat
symptom
inconsist
typic
sar
clinic
manifest
sar
may
vari
divid
light
type
common
type
sever
type
atyp
type
common
type
commonli
seen
base
clinic
develop
could
divid
earli
phase
progress
phase
recoveri
phase
gener
incub
phase
last
day
averag
day
median
day
predominantli
day
initi
symptom
primarili
fever
mostli
high
fever
account
patient
bodi
temperatur
may
reach
highest
fever
type
vari
includ
remitt
fever
irregular
fever
continu
fever
durat
fever
mostli
day
present
headach
joint
orand
systemat
sore
chest
pain
report
incid
headach
sar
patient
sar
patient
cough
dri
scanti
sputum
gener
sar
incur
upper
respiratori
tract
catarrh
symptom
sever
case
may
suffer
acceler
respir
short
breath
even
acut
respiratori
distress
syndrom
character
progress
dyspnea
even
distress
respiratori
frequenc
time
patient
complain
heart
beat
palpit
accompani
often
precordi
discomfort
incid
incid
diarrhea
report
mostli
singl
case
one
characterist
sar
sever
symptom
light
sign
sign
mostli
obviou
even
absent
dyspnea
present
irregular
respiratori
frequenc
depth
rhythm
incid
dyspnea
sar
patient
sever
patient
may
manifest
nose
fan
orthopnea
cyanosi
involv
accessori
respiratori
muscl
respir
well
three
depress
sign
upon
inhal
accord
report
typic
patient
sever
patient
sinu
tachycardia
sar
patient
suffer
paroxysm
supraventricular
tachycardia
pulmonari
sign
sar
patient
frequent
unobvi
absent
earli
phase
light
moist
rale
may
audibl
patient
may
also
demonstr
pulmonari
consolid
sign
attenu
breath
sound
may
also
pleural
effus
light
condit
could
classifi
ed
clinic
light
type
common
typic
type
sever
type
special
atyp
type
followup
visit
sar
patient
via
xray
hrct
choi
et
al
found
patient
develop
fi
brotic
chang
lung
interstitium
shrinkag
lung
volum
applic
glucocorticoid
could
extent
allevi
lung
injuri
patient
sever
infecti
atyp
pneumonia
howev
longterm
abund
use
glucocorticoid
may
gener
numer
side
effect
undisput
fact
hormon
may
induc
femor
head
ischem
necrosi
literatur
report
suggest
incid
femor
head
ischem
necrosi
white
blood
cell
count
remain
within
normal
rang
major
patient
may
decreas
patient
sever
patient
without
secondari
infect
reveal
decreas
total
white
blood
cell
normal
neutrocyt
monocyt
differenti
white
blood
cell
count
howev
initi
diagnos
patient
manifest
decreas
absolut
lymphocyt
count
suggest
tendenc
gradual
declin
morphocytolog
chang
abnorm
lymphocyt
observ
patient
examin
thrombocytopenia
mani
evid
prove
sarscov
could
directli
invad
immun
system
act
mainli
lymphocyt
system
especi
lymphocyt
could
lower
peripher
blood
lymphocyt
peripher
blood
white
cell
count
normal
decreas
sar
patient
lymphocyt
count
distinctli
lower
compar
healthi
popul
sever
condit
drastic
declin
lymphocyt
count
blood
ga
analysi
reveal
hypoxemia
differ
degre
commonli
carbon
dioxid
retent
gener
lmin
oxygen
uptak
patient
sever
hypoxemia
measur
arteri
partial
pressur
oxygen
pao
mmhg
blood
oxygen
satur
spo
develop
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
one
main
immunopathogenesi
chang
sar
patient
insuffi
cienci
tlymphocytemedi
specifi
c
cellular
immun
character
distinct
damag
lymphocyt
subgroup
particularli
exist
distinct
correl
extent
lymphocyt
damag
sever
diseas
method
recommend
test
serum
sarscov
antibodi
enzymelink
immunosorb
assay
elisa
upon
test
sarscovspecifi
c
antibodi
infect
patient
includ
igg
igm
total
antibodi
seroconvers
increas
time
serum
antibodi
progress
phase
recoveri
phase
could
serv
evid
defi
nite
diagnosi
polymeras
chain
reaction
pcr
type
molecular
biolog
test
could
identifi
sar
viru
gene
variou
specimen
blood
fece
respiratori
tract
secret
tissu
section
etc
sar
viru
rna
presenc
follow
three
circumst
could
sar
viru
posit
clinic
specimen
least
two
differ
site
test
posit
nasopharyng
secret
fece
clinic
specimen
collect
least
day
apart
test
posit
two
specimen
nasopharyng
excret
clinic
specimen
test
posit
two
differ
method
differ
laboratori
repeat
pcr
examin
indic
posit
clinic
diagnosi
patient
histori
intim
contact
patient
one
infect
popul
consolid
infect
other
defi
nite
evid
patient
live
area
sar
patient
secondari
infect
epidem
onset
acut
initi
symptom
fever
bodi
temperatur
occasion
accompani
concurr
chill
patient
may
also
suffer
headach
joint
muscular
sore
fatigu
diarrhea
gener
upper
respiratori
tract
catarrh
symptom
patient
may
cough
mostli
dri
scanti
sputum
chest
dull
sever
patient
demonstr
acceler
respir
short
breath
obviou
respiratori
distress
pulmonari
sign
obviou
light
moist
rale
may
audibl
pulmonari
consolid
observ
gener
increas
peripher
white
blood
cell
count
decreas
besid
lymphocyt
count
found
gener
declin
lung
present
differ
degre
patchi
plaqueshap
infi
ltration
shadow
reticul
chang
may
progress
rapidli
larg
patchi
shadow
commonli
occur
multipl
lobe
side
absorpt
dissip
shadow
rel
slow
pulmonari
shadow
symptom
sign
may
inconsist
test
indic
neg
reexamin
shall
conduct
day
remark
respons
antibiot
patient
complianc
follow
three
circumst
diagnos
suspect
case
patient
histori
intim
contact
patient
one
infect
popul
confi
rmed
infect
peopl
concret
evid
also
manifest
aforement
clinic
symptom
high
white
blood
cell
count
test
peripher
blood
patient
live
area
report
infecti
sar
patient
patient
suffer
secondari
infect
week
diseas
onset
also
abovement
clinic
symptom
consist
pulmonari
shadow
chest
xray
fi
lm
abovement
characterist
despit
lack
epidem
data
patient
abovement
clinic
manifest
high
peripher
white
blood
cell
count
well
pulmonari
shadow
chest
xray
accord
abovement
characterist
word
patient
conform
aforement
case
three
follow
circumst
patient
could
clinic
diagnos
sar
patient
histori
intim
contact
patient
one
infect
popul
confi
rmed
infect
peopl
concret
evid
also
manifest
aforement
clinic
symptom
pulmonari
shadow
chest
xray
imag
patient
live
area
report
infecti
sar
patient
patient
suffer
secondari
infect
week
diseas
onset
also
abovement
clinic
symptom
high
peripher
blood
white
cell
count
pulmonari
shadow
chest
xray
fi
lm
patient
live
area
report
infecti
sar
patient
patient
suffer
secondari
infect
week
diseas
onset
also
abovement
clinic
symptom
pulmonari
shadow
chest
xray
fi
lm
obviou
respons
antiinfecti
treatment
word
patient
conform
aforement
condit
mild
without
pulmonari
fi
brosi
sequela
prognosi
good
patient
typic
clinic
manifest
earli
phase
progress
phase
recoveri
phase
onset
acut
fi
rst
symptom
fever
bodi
temperatur
gener
besid
patient
obviou
respiratori
distress
hypoxemia
patient
auscult
slight
moist
rale
observ
pulmonari
consolid
prognosi
good
without
sequela
sever
type
account
common
type
clinic
process
present
sever
condit
rapid
progress
case
may
progress
acut
pulmonari
injuri
ard
rapidli
incur
respiratori
failur
even
death
diagnosi
could
reach
case
follow
three
circumst
dyspnea
adult
respiratori
frequenc
time
min
accompani
one
follow
condit
chest
imag
show
total
surfac
multilobar
lesion
foci
occupi
two
lung
orthotop
imag
condit
progress
focal
area
increas
within
h
account
two
lung
orthotop
imag
obviou
hypoxemia
detect
oxygen
index
lower
mmhg
shock
multiorgan
dysfunct
syndrom
occur
still
atyp
case
diseas
gener
refer
fi
rst
day
onset
acut
initi
symptom
fever
half
patient
accompani
nonspecifi
c
system
symptom
chill
headach
joint
muscular
sore
phase
span
day
diseas
cours
infecti
toxic
symptom
fever
fatigu
muscular
sore
continu
exist
even
aggrav
patient
bodi
temperatur
rise
possibl
higher
short
time
high
fever
persist
lung
lesion
demonstr
progress
exacerb
patient
may
develop
ard
life
threaten
mostli
take
place
day
diseas
cours
patient
good
prognosi
recoveri
week
sever
patient
could
gradual
recov
within
month
discharg
mainli
encompass
stand
chest
xray
bedsid
chest
xray
econom
effect
examin
method
fi
rst
option
examin
preliminari
diagnosi
reexamin
mobil
xray
bedsid
imag
appli
patient
observ
inpati
lung
diseas
sar
patient
progress
rapidli
chest
xray
reexamin
within
short
period
could
help
observ
chang
condit
commonli
everi
day
earli
phase
progress
phase
regular
chest
xray
also
need
conduct
recoveri
phase
ascertain
absorpt
dissip
lesion
residu
foci
pulmonari
interstiti
fi
brosi
sar
patient
ct
scan
gener
prefer
method
necessari
could
conduct
strict
disinfect
quarantin
foci
could
absorb
long
term
sar
recoveri
phase
patient
still
symptom
normal
chest
present
ct
scan
need
carri
observ
better
visual
subtl
pulmonari
interstiti
chang
lung
interlobular
septum
thicken
intralobular
septum
thicken
subpleur
linear
shadow
small
groundglassdens
lesion
region
segment
bronchiectasi
therefor
help
clinic
diagnosi
pulmonari
interstiti
fi
brosi
thinlay
ct
scan
hrct
scan
better
visual
intrapulmonari
lowdens
small
lesion
thu
contributori
earli
diagnosi
pulmonari
interstiti
fi
brosi
ct
examin
could
also
aid
identifi
cation
concurr
lung
lesion
medic
staff
room
imag
examin
depart
radiolog
shall
prevent
infect
strict
complianc
sar
disinfect
prevent
requir
meanwhil
conscienti
implement
xray
protect
ward
shall
equip
bedsid
xray
machin
imag
sar
inpati
shall
conduct
ward
patient
shall
wear
mask
person
protect
imag
technician
subject
leveltwo
protect
requir
necessari
imag
critic
ill
patient
levelthre
protect
requir
xray
fi
lm
magazin
put
isol
bag
imag
one
isol
bag
person
imag
technician
steril
hand
return
radiolog
depart
remov
protect
cloth
glove
protect
glass
design
place
wash
hand
thoroughli
gargl
take
shower
chang
clean
work
cloth
work
depart
must
strengthen
interior
ventil
air
disinfect
ultraviolet
irradi
may
assum
night
time
per
day
minut
per
time
peracet
acid
spray
conduct
time
per
day
rigor
isol
measur
subject
must
wear
mask
oper
staff
must
wear
protect
mask
glove
gown
mask
chang
everi
h
gown
replac
time
use
dispos
bed
sheet
shoe
cover
dispos
replac
time
examin
sar
examin
zone
separ
convent
patient
examin
zone
examin
staff
shall
fi
xed
feasibl
special
chest
xray
examin
room
xray
machin
may
set
isol
zone
avoid
crossinfect
protect
measur
subject
oper
staff
similar
requir
isol
protect
radiolog
depart
subject
must
wear
mask
examin
ct
room
shall
minim
stay
time
much
possibl
patient
leav
environ
articl
may
pollut
patient
shall
given
termin
disinfect
depart
must
enhanc
interior
ventil
air
disinfect
addit
use
chemic
disinfect
spray
may
also
initi
longterm
ultraviolet
irradi
night
disinfect
pathway
specifi
c
sar
patient
establish
chest
xray
diagnosi
imag
manifest
sar
close
relat
patholog
chang
besid
edema
infl
ammatori
cell
infi
ltration
nonspecifi
c
infl
ammatori
chang
promin
pulmonari
patholog
featur
sar
abund
exfoli
epitheli
cell
induc
obviou
thicken
damag
alveolar
septum
well
signific
organ
effus
insid
alveolar
caviti
three
chang
infl
ammat
earli
phase
degener
exud
hyperplasia
observ
mechan
acut
lung
injuri
induc
sar
may
ascrib
sar
coronaviru
direct
attack
alveolar
epithelia
alveolar
capillari
epithelia
indirect
damag
via
lymphocyt
macrophag
effector
cell
lymphokin
cytokin
infl
ammatori
mediat
releas
suggest
besid
viral
direct
infect
immun
reaction
also
involv
lung
injuri
sever
lung
injuri
pulmonari
interstiti
pulmonari
parenchym
air
caviti
chang
detect
autopsi
patholog
especi
pulmonari
air
caviti
complet
fi
lled
lesion
fi
lled
coexist
unfi
lled
alveoli
visual
groundglassdens
shadow
xray
ct
vari
degre
residu
lung
caviti
present
differ
densiti
groundglass
shadow
thinlay
ct
highresolut
ct
hrct
complet
fi
lling
alveolar
space
lead
pulmonari
consolid
shadow
pulmonari
edema
alveolar
hyalin
membran
form
patient
clinic
manifest
decreas
lung
complianc
progress
dyspnea
intract
hypoxemia
rapid
patholog
chang
sar
give
rise
characterist
present
chest
xray
examin
includ
rapid
progress
lesion
divers
morpholog
state
wide
rang
often
span
sever
segment
lobe
therefor
dynam
observ
chest
imag
hold
great
signifi
canc
diagnosi
sar
groundglassdens
shadow
patholog
result
lesion
mainli
pulmonari
interstitium
alveoli
pulmonari
interstiti
lesion
frequent
complic
alveol
groundglassdens
shadow
incur
alveolar
consolid
attribut
partial
fi
lling
alveoli
coexist
fi
lling
unfi
lled
alveoli
shadow
xray
ct
determin
densiti
lesion
lower
blood
vessel
blood
vessel
present
observ
insid
densiti
lesion
lower
pulmonari
hila
xray
could
also
help
identifi
groundglassdens
shadow
pulmonari
consolid
shadow
patholog
due
fi
lling
alveoli
patholog
tissu
frequent
complic
lung
interstiti
lesion
pulmonari
consolid
could
confi
rmed
lesion
found
higher
densiti
vascular
shadow
without
vascular
shadow
insid
air
bronchogram
xray
ct
could
also
determin
lesion
present
higher
densiti
pulmonari
hila
similar
densiti
mediastinum
lesion
solitari
multipl
small
patch
lesion
distribut
along
lung
lobe
segment
sar
patient
may
develop
subsequ
solitari
multipl
small
patchi
shadow
within
seven
day
onset
rel
low
densiti
blurri
border
irregular
shape
predominantli
solitari
occasion
pulmonari
textur
around
lesion
reveal
increas
thicken
mainli
distribut
peripher
area
commonli
bilater
inferior
lung
sinc
chest
xray
poorli
visual
rel
small
lesion
sometim
posteroanterior
xray
hardli
display
lesion
overlap
heart
shadow
orthotop
chest
imag
conduct
time
fig
condit
patient
becom
wors
within
day
onset
small
patchi
shadow
earli
phase
may
progress
larg
patchi
multipl
diffus
lesion
lesion
may
spread
unilater
lung
lung
one
lung
fi
eld
sever
fi
eld
sever
patient
may
demonstr
obviou
chang
day
onset
lesion
present
mainli
groundglassdens
shadow
coexist
lung
consolid
shadow
center
shadow
high
densiti
indic
consolid
rel
lowdens
peripher
area
suggest
groundglass
fig
male
patient
diagnos
sar
specifi
c
segment
rtpcr
sr
viru
posit
day
onset
right
inferior
lung
fi
eld
observ
patchi
illdemarc
shadow
increas
densiti
densiti
may
complic
thicken
increas
pulmonari
textur
sever
patient
may
develop
white
lung
case
may
pneumothorax
pneumomediastinum
subcutan
emphysema
use
ventil
small
part
lesion
adjac
pleura
may
complic
local
pleural
thicken
reveal
mild
tentiform
adhes
pleural
chang
may
resid
absorpt
intrapulmonari
lesion
complic
slight
pleural
effus
may
also
observ
fig
lesion
sar
patient
begin
absorb
day
complet
absorb
major
patient
patient
may
show
pulmonari
fi
brosi
pulmonari
interstiti
hyperplasia
appar
pulmonari
interstiti
hyperplasia
occur
day
onset
intrapulmonari
patchi
shadow
present
shrinkag
increas
densiti
gradual
form
highdens
cordlik
honeycombshap
shadow
lung
sever
pulmonari
interstiti
prolifer
could
dwindl
lung
volum
make
mediastinum
shift
affect
side
imag
may
reveal
local
irregular
highdens
plaqu
cordshap
shadow
occurr
intrapulmonari
honeycombshap
shadow
traction
bronchiectasi
characterist
pulmonari
interstiti
fi
brosi
fig
rapid
chang
import
featur
sar
chest
xray
manifest
dynam
xray
studi
observ
could
provid
evid
sar
defi
nite
diagnosi
therefor
observ
diseas
dynam
chang
critic
sar
chest
xray
major
differ
xray
examin
pneumonia
earli
phase
progress
phase
sar
lung
foci
may
undergo
remark
chang
within
short
time
h
shortest
expans
dissemin
character
chang
shape
extent
site
foci
suggest
clinic
physician
shall
conduct
chest
orthotop
imag
everi
h
sar
patient
hospit
ascertain
diseas
chang
imag
dynam
chang
associ
multipl
factor
age
origin
underli
diseas
treatment
method
effi
caci
lesion
gener
absorb
day
onset
possibl
day
mild
patient
focal
shadow
may
becom
smaller
densiti
gradual
decreas
one
characterist
dynam
chang
sar
migrat
chang
lesion
patient
suggest
foci
fi
rstli
occur
unilater
inferior
lung
fi
eld
spread
contralater
andor
superior
middl
lung
fi
eld
patient
wors
lesion
may
manifest
wider
imag
extent
new
foci
sever
patient
may
develop
white
lung
ard
key
caus
lead
death
patient
fig
lung
imag
examin
import
basi
sar
diagnosi
continu
imag
examin
could
visual
dynam
chang
characterist
diseas
sar
infect
chest
abnorm
chang
frequent
occur
day
initi
phase
focal
shadow
frequent
seen
might
unilater
dominantli
bilater
ct
reveal
small
patchi
groundglassdens
shadow
quasicircular
lesion
present
solitari
small
patchi
lung
consolid
multipl
small
patchi
rel
larg
patchi
shadow
larg
foci
may
appear
groundglassdens
shadow
concurr
lung
consolid
shadow
rel
higherdens
vascular
shadow
observ
former
besid
foci
found
increas
vascular
shadow
peripheri
addit
lesion
unveil
frequent
bilater
lung
inferior
fi
eld
lung
margin
fig
lesion
major
patient
may
progress
worsen
within
day
onset
small
patchi
shadow
earli
phase
could
expand
larg
patchi
multipl
diffus
lesion
within
day
besid
lesion
extend
unilater
lung
bilater
lung
one
lung
fi
eld
multipl
lung
fi
eld
patient
could
develop
severest
infi
ltration
lung
day
name
peak
phase
critic
phase
ct
present
still
predomin
groundglassdens
shadow
may
complic
pulmonari
consolid
lesion
commonli
multipl
diffus
distribut
lung
lesion
vari
shape
may
coexist
quasicircular
foci
rel
common
case
appear
groundglassdens
shadow
time
onset
absorpt
lesion
groundglassdens
shadow
complic
pulmonari
consolid
larg
patchi
small
patchi
quasicircular
groundglassdens
shadow
could
observ
pulmonari
consolid
shadow
rel
high
densiti
groundglass
densiti
pulmonari
consolid
may
also
occur
differ
part
lung
could
visual
layer
differ
layer
ct
lesion
typic
pulmonari
consolid
pulmonari
consolid
appear
plaqueshap
highdens
shadow
consolid
sign
lung
lobe
segment
addit
lesion
frequent
record
lung
lobe
segment
inferior
lobe
outer
band
lung
fi
eld
fig
lesion
usual
begin
absorb
week
onset
shadow
shrunk
densiti
gradual
reduc
absorb
although
clinic
symptom
patient
improv
disappear
light
groundglassdens
shadow
could
still
seen
lung
ct
may
prolong
rel
long
time
absorpt
intrapulmonari
lesion
also
concurr
pulmonari
interstiti
prolifer
begin
absorb
dynam
observ
lesion
may
develop
pulmonari
interstiti
fi
brosi
character
lobular
septum
intralobular
septum
interstiti
thicken
subpleur
curvatur
imag
sign
well
region
irregular
highdens
plaqu
cordlik
present
occurr
intrapulmonari
honeycomb
manifest
traction
bronchiectasi
signifi
es
pulmonari
interstiti
fi
brosi
fig
sar
complic
import
factor
affect
prognosi
given
enorm
attent
sar
treatment
antivir
drug
administ
well
glucocorticoid
broadspectrum
antibiot
patient
may
still
need
airway
posit
pressur
ventil
tracheotomi
tracheal
intub
reason
use
measur
great
signifi
canc
improv
treatment
rate
lower
mortal
sar
patient
howev
note
treatment
drug
method
may
incur
advers
reaction
caus
complic
sar
complic
alreadi
detect
encompass
pulmonari
secondari
infect
mediastin
subcutan
emphysema
pneumothorax
bone
asept
necrosi
empyema
brain
secondari
infect
pulmonari
interstiti
interstiti
fibrosi
earli
phase
sar
manifest
bronchiolar
peripher
interstiti
pneumonia
could
progress
patchi
groundglass
blurri
shadow
bilater
superior
middl
inferior
lung
fi
eld
consolid
air
bronchogram
differ
layer
alveolar
consolid
interstiti
lesion
present
persist
mostli
revers
recoveri
phase
case
develop
pulmonari
interstiti
prolifer
caus
fi
brotic
chang
pulmonari
interstiti
prolifer
fi
brosi
degre
outcom
associ
extent
pulmonari
involv
peak
phase
occurr
complic
treatment
gener
lesion
chest
imag
light
peak
phase
fewer
pulmonari
chang
left
recoveri
phase
contrarili
patient
diffus
lung
interstiti
thicken
recoveri
phase
often
suffer
rel
sever
pulmonari
injuri
peak
phase
involv
great
mass
lung
particularli
patient
recurr
condit
protract
cours
concurr
infect
research
demonstr
sar
patient
pulmonari
fi
brosi
vari
degre
male
patient
display
rel
obviou
pulmonari
impair
femal
patient
primari
manifest
lung
dysfunct
decreas
pulmonari
diffus
capac
lung
capac
impair
chang
total
lung
capac
particularli
residu
volum
gener
obviou
pulmonari
interstiti
prolifer
occur
day
onset
present
fi
rstli
lobular
septum
intralobular
thicken
subpleur
curvatur
shadow
shrinkag
intrapulmonari
patchi
shadow
increas
densiti
gradual
format
highdens
cord
honeycomb
shadow
insid
lung
sever
pulmonari
interstiti
prolifer
could
diminish
lung
volum
compel
mediastinum
affect
side
besid
pulmonari
interstiti
prolifer
could
occur
extens
insid
lung
predomin
lobular
septum
intralobular
interstiti
thicken
subpleur
curvatur
shadow
well
irregular
highdens
plaqu
cordlik
shadow
region
honeycombshap
shadow
traction
bronchiectasi
sign
pulmonari
interstiti
fi
brosi
ct
reveal
cord
reticul
honeycombshap
shadow
hrct
could
better
visual
subtl
abnorm
chang
pulmonari
interstitium
lobular
septum
thicken
intralobular
interstiti
thicken
subpleur
curvatur
shadow
honeycombshap
shadow
whether
cordlik
reticul
chang
visual
ct
complet
absorb
induc
persist
fi
brosi
still
entail
longterm
followup
observ
fig
numer
sar
patient
develop
osteonecrosi
recoveri
mostli
appear
femor
head
necrosi
also
possibl
necrosi
ankl
joint
knee
joint
shoulder
joint
scan
bilater
hip
knee
sar
patient
rehabilit
phase
disclos
patient
suffer
osseou
abnorm
bone
ischemia
account
implic
three
site
pathogenesi
still
remain
complet
ascertain
may
ascrib
improp
use
hormon
injuri
sclerotin
sar
virus
bacteri
embol
lipid
embol
multipl
mix
factor
primari
patholog
chang
asept
necrosi
femor
head
degen
alter
due
femor
head
blood
circul
disturb
mainli
character
limp
pain
lower
limb
affect
side
rel
shorter
present
light
fl
exion
adduct
well
slightli
limit
abduct
intors
initi
xray
examin
suggest
involv
femor
head
normal
appear
inhomogen
densiti
spot
osteoporosi
gradual
ensu
increas
densiti
result
osteonecrosi
meanwhil
interspers
transpar
shadow
femor
head
may
becom
fl
fragment
irregular
contour
pressur
typic
femor
head
necrosi
appear
shape
wedg
base
toward
articular
surfac
top
toward
metaphysi
sinc
lesion
dominantli
confi
ned
anterosuperior
area
femor
head
later
imag
hip
joint
could
clearli
reproduc
extent
lesion
necrot
area
encircl
ring
transpar
band
hip
articular
caviti
may
becom
wider
irregular
due
fl
atten
femur
sometim
may
complic
disloc
fragment
femor
head
may
shed
joint
give
rise
joint
mous
normal
femor
head
locat
acetabular
center
transvers
ct
imag
may
appear
shape
sphere
hook
differ
layer
delic
highdens
bone
cortex
peripheri
highdens
trabecula
insid
femor
head
arrang
stelliform
format
center
continu
bone
cortex
name
stelliform
sign
ct
manifest
asept
necrosi
femor
head
divid
earli
advanc
phase
earli
phase
stelliform
sign
form
trabecula
femor
head
deform
absent
present
spot
patchi
shadow
increas
densiti
insid
femor
head
fascicul
chang
mutual
fusion
peripheri
advanc
phase
femor
head
becom
ruptur
shape
absorpt
sclerotin
bone
fragment
appear
irregular
lowdens
area
stelliform
sign
disappear
mri
manifest
asept
necrosi
femor
head
includ
necrot
area
femor
head
earli
case
repair
reaction
mechan
collaps
still
maintain
normal
lipid
signal
medullari
bone
howev
lowsign
margin
incur
sclerosi
reaction
could
seen
peripheri
foci
high
signal
normal
femor
head
imag
detect
black
linear
low
signal
repres
demarc
normal
ischem
bone
tissu
imag
highsign
line
visibl
medial
lowsign
sclerot
reaction
line
thu
form
typic
doublelin
sign
doublelin
sign
could
refl
ect
congest
infl
ammat
granul
tissu
prove
specifi
c
asept
necrosi
femor
head
sever
infl
ammat
congest
fi
brosi
sclerosi
could
greatli
deplet
amount
lipid
femor
head
present
liquidlik
signal
mri
low
signal
imag
high
signal
imag
advanc
case
typic
fi
brosi
sclerosi
affect
area
present
fi
brotic
mri
featur
low
signal
proton
densityweight
imag
complic
effus
hip
joint
appear
low
signal
high
signal
base
mri
present
asept
necrosi
femor
head
could
classifi
ed
four
phase
phase
character
homogen
inhomogen
lowsign
area
adjac
joint
femor
head
imag
phase
ii
visual
wedgeshap
lowsign
band
phase
iii
present
sequestrum
crescent
sign
cortex
collaps
phase
iv
manifest
joint
degener
joint
space
narrow
besid
present
phase
iii
light
aforement
mr
stage
criteria
sar
case
complic
asept
necrosi
femor
head
alreadi
report
mostli
phase
ii
addit
asept
necrosi
use
hormon
besid
frequent
involv
femor
head
could
also
implic
joint
knee
joint
elbow
joint
ankl
joint
acetabulum
therefor
necessari
mr
examin
joint
shall
conduct
ascertain
extent
degre
lesion
sar
patient
complain
pain
hip
joint
limit
movement
ct
scan
mri
examin
hip
joint
recommend
conclud
defi
nite
diagnosi
xray
plain
scan
sensit
earli
bone
ischem
necrosi
therefor
prefer
fig
